Soluble urokinase plasminogen activator receptor and decline in kidney function among patients without kidney disease

BACKGROUND: Hospitalized patients are at an increased risk of developing kidney disease after discharge, often despite the absence of any clinical indicators during hospitalization. Soluble urokinase plasminogen activator receptor (suPAR) is a marker of systemic chronic inflammation that can be meas...

Descripción completa

Detalles Bibliográficos
Autores principales: Iversen, Esben, Kallemose, Thomas, Hornum, Mads, Bengaard, Anne Kathrine, Nehlin, Jan Olof, Rasmussen, Line Jee Hartmann, Sandholdt, Haakon, Tavenier, Juliette, Feldt-Rasmussen, Bo, Andersen, Ove, Eugen-Olsen, Jesper, Houlind, Morten Baltzer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9308102/
https://www.ncbi.nlm.nih.gov/pubmed/35892012
http://dx.doi.org/10.1093/ckj/sfac048

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9308102/
https://www.ncbi.nlm.nih.gov/pubmed/35892012
http://dx.doi.org/10.1093/ckj/sfac048

Ejemplares similares